SciBase Holding AB (publ) (FRA:5J30)

Market Cap	29.81M +153.0%
Revenue (ttm)	4.18M +41.2%
Net Income	-8.28M
EPS	-1.69
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	2.775
Previous Close	2.875
Day's Range	2.775 - 2.775
52-Week Range	0.020 - 4.440
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 19, 2026

About SciBase Holding AB

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Ne...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1998
• Employees: 49
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5J30

Financial Performance

In 2025, SciBase Holding AB's revenue was 40.46 million, an increase of 36.21% compared to the previous year's 29.71 million. Losses were -87.06 million, 32.8% more than in 2024.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error